CCM
JAZZ icon

Covington Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Covington Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$2K – 1035
2021
Q3 		$2K Buy
+16
New +$2.42K ﹤0.01% 951
2019
Q2 		– Sell
-33
Closed -$5K – 789
2019
Q1 		$5K Buy
+33
New +$4.3K ﹤0.01% 667

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Covington Capital Management's JAZZ Position: Q4 2021 in Review

Covington Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 16 shares — an estimated $2K sold.

Covington Capital Management first reported a position in JAZZ in Q1 2019 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • Covington Capital Management reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Covington Capital Management sold 16 Jazz Pharmaceuticals shares in Q4 2021, an estimated $2K.
  • Covington Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Covington Capital Management's Jazz Pharmaceuticals position peaked at $5K in Q1 2019.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Covington Capital Management's 13F filing for Q4 2021, filed 16 Feb 2022.